Gohealth Updates Its FY23 Revenue Outlook To $800M-$850M From Prior Guidance Of $750M-$850M Versus Consensus Of $779.09M; Sees Adjusted EBITDA Of $120M-$140M Compared To Prior Guidance Of $100M-$140M
Portfolio Pulse from Benzinga Newsdesk
GoHealth has updated its FY23 revenue outlook to $800M-$850M, up from the previous guidance of $750M-$850M. The consensus was $779.09M. The company also increased its adjusted EBITDA forecast to $120M-$140M, compared to the prior guidance of $100M-$140M.
August 10, 2023 | 10:19 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
GoHealth's updated FY23 revenue and EBITDA guidance, both higher than previous estimates, could positively impact its stock price.
GoHealth's updated guidance indicates a stronger financial performance than previously expected. This could increase investor confidence and drive up the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100